Danielle Antalffy
Stock Analyst at UBS
(3.58)
# 856
Out of 5,040 analysts
182
Total ratings
50%
Success rate
6.14%
Average return
Main Sectors:
Stocks Rated by Danielle Antalffy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BSX Boston Scientific | Maintains: Buy | $135 → $140 | $102.39 | +36.73% | 14 | Oct 23, 2025 | |
| JNJ Johnson & Johnson | Maintains: Buy | $190 → $214 | $192.47 | +11.19% | 6 | Oct 14, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Neutral | $230 → $89 | $80.17 | +11.01% | 7 | Sep 22, 2025 | |
| MDT Medtronic | Maintains: Neutral | $94 → $95 | $94.21 | +0.84% | 11 | Aug 20, 2025 | |
| TMCI Treace Medical Concepts | Maintains: Neutral | $8.6 → $6.5 | $6.79 | -4.27% | 7 | Aug 8, 2025 | |
| RXST RxSight | Maintains: Neutral | $16 → $8 | $8.43 | -5.10% | 4 | Aug 8, 2025 | |
| ENOV Enovis | Maintains: Buy | $65 → $57 | $32.52 | +75.30% | 2 | Aug 8, 2025 | |
| ZBH Zimmer Biomet Holdings | Maintains: Sell | $91 → $96 | $103.16 | -6.94% | 5 | Aug 8, 2025 | |
| TNDM Tandem Diabetes Care | Maintains: Neutral | $20 → $17 | $14.66 | +15.96% | 15 | Aug 7, 2025 | |
| BAX Baxter International | Maintains: Neutral | $35 → $24 | $22.99 | +4.39% | 6 | Aug 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $134 | $75.23 | +78.12% | 2 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $105 → $106 | $71.06 | +49.17% | 9 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $547 → $585 | $551.30 | +6.11% | 2 | Jul 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $58 | $37.39 | +55.12% | 13 | Apr 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $19 → $16 | $15.48 | +4.97% | 4 | Apr 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $5 | $5.20 | -3.85% | 2 | Jan 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $146 → $148 | $126.34 | +17.14% | 12 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $366 → $370 | $383.06 | -3.41% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $75 | $76.53 | -2.00% | 12 | Sep 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $2.25 | $2.22 | +1.35% | 1 | Mar 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $280 | $323.46 | -13.44% | 12 | May 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $975 → $825 | $15.20 | +5,327.63% | 2 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $12 → $14 | $18.05 | -22.44% | 1 | May 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $75 → $100 | $56.52 | +76.94% | 2 | May 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $15 → $12 | $10.54 | +13.85% | 3 | Mar 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $25 → $30 | $34.62 | -13.34% | 3 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $40 → $45 | $35.97 | +25.10% | 4 | Feb 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $270 → $275 | $186.53 | +47.43% | 1 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $26 → $20 | $4.11 | +386.62% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $72 → $42 | $8.97 | +368.23% | 7 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | $60 | $7.35 | +716.33% | 3 | Apr 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $15 | $0.84 | +1,681.47% | 1 | Sep 1, 2020 |
Boston Scientific
Oct 23, 2025
Maintains: Buy
Price Target: $135 → $140
Current: $102.39
Upside: +36.73%
Johnson & Johnson
Oct 14, 2025
Maintains: Buy
Price Target: $190 → $214
Current: $192.47
Upside: +11.19%
Inspire Medical Systems
Sep 22, 2025
Downgrades: Neutral
Price Target: $230 → $89
Current: $80.17
Upside: +11.01%
Medtronic
Aug 20, 2025
Maintains: Neutral
Price Target: $94 → $95
Current: $94.21
Upside: +0.84%
Treace Medical Concepts
Aug 8, 2025
Maintains: Neutral
Price Target: $8.6 → $6.5
Current: $6.79
Upside: -4.27%
RxSight
Aug 8, 2025
Maintains: Neutral
Price Target: $16 → $8
Current: $8.43
Upside: -5.10%
Enovis
Aug 8, 2025
Maintains: Buy
Price Target: $65 → $57
Current: $32.52
Upside: +75.30%
Zimmer Biomet Holdings
Aug 8, 2025
Maintains: Sell
Price Target: $91 → $96
Current: $103.16
Upside: -6.94%
Tandem Diabetes Care
Aug 7, 2025
Maintains: Neutral
Price Target: $20 → $17
Current: $14.66
Upside: +15.96%
Baxter International
Aug 4, 2025
Maintains: Neutral
Price Target: $35 → $24
Current: $22.99
Upside: +4.39%
Jul 31, 2025
Maintains: Buy
Price Target: $125 → $134
Current: $75.23
Upside: +78.12%
Jul 31, 2025
Maintains: Buy
Price Target: $105 → $106
Current: $71.06
Upside: +49.17%
Jul 23, 2025
Maintains: Neutral
Price Target: $547 → $585
Current: $551.30
Upside: +6.11%
Apr 30, 2025
Maintains: Buy
Price Target: $60 → $58
Current: $37.39
Upside: +55.12%
Apr 29, 2025
Maintains: Neutral
Price Target: $19 → $16
Current: $15.48
Upside: +4.97%
Jan 27, 2025
Maintains: Buy
Price Target: $5.5 → $5
Current: $5.20
Upside: -3.85%
Jan 23, 2025
Maintains: Buy
Price Target: $146 → $148
Current: $126.34
Upside: +17.14%
Oct 30, 2024
Maintains: Neutral
Price Target: $366 → $370
Current: $383.06
Upside: -3.41%
Sep 10, 2024
Maintains: Neutral
Price Target: $90 → $75
Current: $76.53
Upside: -2.00%
Mar 29, 2023
Initiates: Neutral
Price Target: $2.25
Current: $2.22
Upside: +1.35%
May 6, 2022
Maintains: Outperform
Price Target: $300 → $280
Current: $323.46
Upside: -13.44%
May 5, 2022
Maintains: Outperform
Price Target: $975 → $825
Current: $15.20
Upside: +5,327.63%
May 5, 2022
Maintains: Outperform
Price Target: $12 → $14
Current: $18.05
Upside: -22.44%
May 2, 2022
Maintains: Outperform
Price Target: $75 → $100
Current: $56.52
Upside: +76.94%
Mar 11, 2022
Maintains: Outperform
Price Target: $15 → $12
Current: $10.54
Upside: +13.85%
Mar 9, 2022
Maintains: Outperform
Price Target: $25 → $30
Current: $34.62
Upside: -13.34%
Feb 25, 2022
Maintains: Outperform
Price Target: $40 → $45
Current: $35.97
Upside: +25.10%
Feb 4, 2022
Maintains: Market Perform
Price Target: $270 → $275
Current: $186.53
Upside: +47.43%
Nov 10, 2021
Maintains: Outperform
Price Target: $26 → $20
Current: $4.11
Upside: +386.62%
Nov 5, 2021
Maintains: Market Perform
Price Target: $72 → $42
Current: $8.97
Upside: +368.23%
Apr 1, 2021
Downgrades: Market Perform
Price Target: $60
Current: $7.35
Upside: +716.33%
Sep 1, 2020
Initiates: Outperform
Price Target: $15
Current: $0.84
Upside: +1,681.47%